Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yohei Sekino

Showing results (11-20 of 119) with videos related to

Pageof 12
Sort By:
Oncology|August 23, 2018
TDO2 Overexpression Is Associated with Cancer Stem Cells and Poor Prognosis in Esophageal Squamous Cell CarcinomaQuoc Thang Pham, Naohide Oue, Yohei Sekino, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|June 9, 2022
Essential Roles of TDO2 in Gastric Cancer: TDO2 Is Associated with Cancer Progression, Patient Survival, PD-L1 Expression, and Cancer Stem CellsQuoc Thang Pham, Daiki Taniyama, Shintaro Akabane, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|June 5, 2019
SEC11A Expression Is Associated with Basal-Like Bladder Cancer and Predicts Patient SurvivalYoshinori Shigematsu, Naohide Oue, Yohei Sekino, et al.
Oncotarget|December 8, 2017
Transcribed ultraconserved region Uc.63+ promotes resistance to docetaxel through regulation of androgen receptor signaling in prostate cancerYohei Sekino, Naoya Sakamoto, Keisuke Goto, et al.
The Prostate|June 3, 2020
High-throughput screen identifies 5-HT receptor as a modulator of AR and a therapeutic target for prostate cancerMomoe Itsumi, Masaki Shiota, Yohei Sekino, et al.
Journal of Clinical Medicine|February 13, 2019
KIFC1 Inhibitor CW069 Induces Apoptosis and Reverses Resistance to Docetaxel in Prostate CancerYohei Sekino, Naohide Oue, Yuki Koike, et al.
Scientific Reports|August 23, 2022
Evaluation of urinary catheters for effective manual bladder washoutKohei Kobatake, Shogo Inoue, Kenshiro Takemoto, et al.
Oncology Letters|July 12, 2017
Overexpression of the transmembrane protein BST-2 induces Akt and Erk phosphorylation in bladder cancerYoshinori Shigematsu, Naohide Oue, Yuri Nishioka, et al.
Journal of Clinical Medicine|February 6, 2019
Fibroblast Growth Factor Family in the Progression of Prostate CancerJun Teishima, Tetsutaro Hayashi, Hirotaka Nagamatsu, et al.
Frontiers in Oncology|October 13, 2025
Case Report: Locally advanced clear cell renal cell carcinoma with pathological complete response following nephrectomy and thrombectomy after nivolumab and cabozantinib treatmentHayato Yoshioka, Hiroyuki Kitano, Kohei Kobatake, et al.
Pageof 12

Showing results (11-20 of 119) with videos related to

Sort By:
Pageof 12
Oncology|August 23, 2018
TDO2 Overexpression Is Associated with Cancer Stem Cells and Poor Prognosis in Esophageal Squamous Cell CarcinomaQuoc Thang Pham, Naohide Oue, Yohei Sekino, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|June 9, 2022
Essential Roles of TDO2 in Gastric Cancer: TDO2 Is Associated with Cancer Progression, Patient Survival, PD-L1 Expression, and Cancer Stem CellsQuoc Thang Pham, Daiki Taniyama, Shintaro Akabane, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|June 5, 2019
SEC11A Expression Is Associated with Basal-Like Bladder Cancer and Predicts Patient SurvivalYoshinori Shigematsu, Naohide Oue, Yohei Sekino, et al.
Oncotarget|December 8, 2017
Transcribed ultraconserved region Uc.63+ promotes resistance to docetaxel through regulation of androgen receptor signaling in prostate cancerYohei Sekino, Naoya Sakamoto, Keisuke Goto, et al.
The Prostate|June 3, 2020
High-throughput screen identifies 5-HT receptor as a modulator of AR and a therapeutic target for prostate cancerMomoe Itsumi, Masaki Shiota, Yohei Sekino, et al.
Journal of Clinical Medicine|February 13, 2019
KIFC1 Inhibitor CW069 Induces Apoptosis and Reverses Resistance to Docetaxel in Prostate CancerYohei Sekino, Naohide Oue, Yuki Koike, et al.
Scientific Reports|August 23, 2022
Evaluation of urinary catheters for effective manual bladder washoutKohei Kobatake, Shogo Inoue, Kenshiro Takemoto, et al.
Oncology Letters|July 12, 2017
Overexpression of the transmembrane protein BST-2 induces Akt and Erk phosphorylation in bladder cancerYoshinori Shigematsu, Naohide Oue, Yuri Nishioka, et al.
Journal of Clinical Medicine|February 6, 2019
Fibroblast Growth Factor Family in the Progression of Prostate CancerJun Teishima, Tetsutaro Hayashi, Hirotaka Nagamatsu, et al.
Frontiers in Oncology|October 13, 2025
Case Report: Locally advanced clear cell renal cell carcinoma with pathological complete response following nephrectomy and thrombectomy after nivolumab and cabozantinib treatmentHayato Yoshioka, Hiroyuki Kitano, Kohei Kobatake, et al.
Pageof 12